448961-57-7 Usage
Uses
Used in Pharmaceutical Industry:
2,3-DiMethyl-4-Methoxybenzonitrile is used as a chemical intermediate for the synthesis of various pharmaceuticals, leveraging its ability to form carbon-nitrogen triple bonds and participate in nucleophilic aromatic substitution reactions, which are essential for creating complex organic molecules with therapeutic potential.
Used in Dye Industry:
DM4MN is used as a dye intermediate, contributing to the production of dyes that have specific color properties and are used in various applications, including textiles, plastics, and printing inks.
Used in Agricultural Chemicals:
2,3-DiMethyl-4-Methoxybenzonitrile is used as a precursor in the production of insecticides, herbicides, and fungicides, where its reactivity and structural features are utilized to create compounds that effectively control pests and diseases in agriculture.
Used in Organic Chemistry Research:
DM4MN is used as a reagent in organic chemistry for the creation of carbon-carbon bonds, particularly through nucleophilic aromatic substitution, which is a fundamental reaction in the synthesis of complex organic molecules and the development of new chemical entities.
Check Digit Verification of cas no
The CAS Registry Mumber 448961-57-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,4,8,9,6 and 1 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 448961-57:
(8*4)+(7*4)+(6*8)+(5*9)+(4*6)+(3*1)+(2*5)+(1*7)=197
197 % 10 = 7
So 448961-57-7 is a valid CAS Registry Number.
448961-57-7Relevant academic research and scientific papers
Design and synthesis of 1,2,4-oxadiazole derivatives as non-steroidal 5α-reductase inhibitors
Chang, Chih-Shiang,Kan, Wai Ming,Chen, Chiu-Liang,Wang,Chern, Ji-Wang
, p. 83 - 89 (2007/10/03)
The purpose of this study was to synthesize compounds in which the 1,2,4-oxadiazole moiety replaced the amide bond of ONO3805 and to evaluate its 5α-reductase inhibitory activity as a potential benign prostatic hyperplasia therapeutic target. Four 1,2,4-o
